Histone deacetylase inhibitor

Histone deacetylase inhibitor
Drug class
Vorinostat (SAHA; Zolinza), the first-approved and most-widely-known HDAC inhibitor.
Class identifiers
SynonymsHDAC inhibitor; HDACi; HDI
Mechanism of actionHistone deacetylase inhibition
Biological targetHistone deacetylases (HDACs)
Chemical classVarious
Legal status
In Wikidata

Histone deacetylase inhibitors (HDAC inhibitors, HDACi, HDIs) are chemical compounds that inhibit histone deacetylases. Since deacetylation of histones produces transcriptionally silenced heterochromatin, HDIs can render chromatin more transcriptionally active and induce epigenomic changes.

HDIs have a long history of use in psychiatry and neurology as mood stabilizers and anti-epileptics, such as valproic acid. Since at least 2003 they have been investigated as possible treatments for cancers, parasitic and inflammatory diseases.